AMAM - Ambrx Biopharma 10% owner discloses purchase of 1.31M shares
2023-10-26 10:46:42 ET
More on Ambrx Biopharma
- Ambrx: Next-Generation Antibody-Drug Conjugates, Buying The Dip After ESMO Data
- Ambrx Biopharma: Potential With Recently Released Prostate Cancer Data
- Ambrx Biopharma falls after Phase 1/2 data for prostate cancer therapy
- Historical earnings data for Ambrx Biopharma
For further details see:
Ambrx Biopharma 10% owner discloses purchase of 1.31M shares